Public health and the placebo: The legacy of the 1906 pure food and drugs act

Cato Journal

Volumn 21, Issue 3, 2002, Pages 463-479

  Sobel, Russell S ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4644347128     PISSN: 02733072     EISSN: 02733072     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Bootzin, R. R. (1985) "The Role of Expectancy in Behavior Change." In L. White, B. Tursky, and G. Schwartz (eds.) Placebo: Theory, Research, and Mechanisms. New York: Guilford Press.
2. Brody, H. (1980) Placebos and the Philosophy of Medicine: Clinical, Conceptual, and Ethical Issues. Chicago: University of Chicago Press.
3. Dranove, D. (1991) "The Costs of Compliance with the 1962 FDA Amendments." Journal of Health Economics 10 (July): 235-38.
4. Dranove, D., and Meltzer, D. (1994) "Do important Drugs Reach the Market Sooner?" Rand Journal of Economics 23 (Autumn): 402-23.
5. Evans, F. (1985) "Expectancy, Therapeutic Instructions, and the Placebo Response." In White, Tursky, and Schwartz (eds.) Placebo: Theory, Research, and Mechanisms. New York: Guilford Press.
6. Finkel, M. J. (1985) "Placebo Controls Are Not Always Necessary." In White, Tursky, and Schwartz (eds.) Placebo: Theory, Research, and Mechanisms. New York: Guilford Press.
7. Gieringer, D. H. (1985) "The Safety and Efficacy of New Drug Approval." Cato Journal 5 (Spring-Summer): 177-201.
8. Holbrook, S. H. (1959) The Golden Age of Quackery. New York: Macmillan.
9. Holcombe, R. G. (1995) Public Policy and the Quality of Life. Westport, Conn.: Greenwood Press.
10. Hrobjartsson, A., and Gotzsche, P. C. (2001) "Is the Placebo Powerless?-An Analysis of Clinical Trials Comparing Placebo with No Treatment." New England Journal of Medicine 344 (24 May):1594-1602.
11. Jarrell, G., and Peltzman, S. (1985) "The Impact of Product Recalls on the Wealth of Sellers." Journal of Political Economy 93 (June): 512-36.
12. Klein, D. B. (2000) "Economists Against the FDA." Ideas on Liberty 50 (September): 18-21.
13. Pearson, D., and Shaw, S. (1993) Freedom of Informed Choice: FDA Versus Nutrient Supplements. Neptune, N.J.: Common Sense Press.
14. Peltzman, S. (1973) "An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments." Journal of Political Economy 81 (September-October): 1049-91.
15. Rawlinson, M. C. (1985) "Truth-Telling and Paternalism in the Clinic: Philosophical Reflections on the Use of Placebos in Medical Practice." In White, Tursky, and Schwartz (eds.) Placebo: Theory, Research, and Mechanisms. New York: Guilford Press.
16. Tabarrok, A. T. (2000) "Assessing the FDA via the Anomaly of Off-Label Drug Prescribing." The Independent Review 5 (Summer): 25-53.
17. Wickramasekera, I. (1985) "A Conditioned Response Model of the Placebo Effect." In White, Tursky, and Schwartz (eds.) Placebo: Theory, Research, and Mechanisms. New York: Guilford Press.
18. Young, J. H. (1961) The Toadstool Millionaires. Princeton, N.J.: Princeton University Press.